Test Price
2,800 AED✅ Home Collection Available
SLC16A2 Gene Allan-Herndon-Dudley Syndrome Genetic Test in UAE | 2800 AED | DHA Approved
Executive Summary & Core Metrics
- ✓99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratory and DHA-Approved Partner.
- ✓VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
- ✓Post-Test Telephonic Clinical Guidance for result interpretation and family counselling.
- ✓Insurance Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SLC16A2 gene Allan-Herndon-Dudley syndrome NGS test sequences the entire coding region of the MCT8 thyroid hormone transporter gene using Next Generation Sequencing, delivering a diagnostic yield above 99% for this X-linked intellectual disability. This comprehensive analysis detects point mutations, insertions/deletions, and copy number variations, providing conclusive genetic evidence for diagnosis, carrier status, and prenatal planning.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Coverage | Full gene (exons + splice sites) | Known pathogenic variants only |
| Detection Power | Novel & rare mutations | May miss private mutations |
| Turnaround | 3–4 Weeks | 4–6 Weeks |
| Price | 2,800 AED | ~2,400 AED (limited scope) |
| Clinical Utility | Confirms diagnosis, carrier status, prenatal planning | Confirms known familial mutation only |
Physician Insight & Safety Protocols
“Allan‑Herndon‑Dudley syndrome presents in early infancy with hypotonia and severe developmental delay; this NGS test provides conclusive genetic evidence. Results must be correlated with thyroid function tests and neurological examination. I strongly advise pre‑ and post‑test genetic counselling to fully interpret the implications for patient care and family planning.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Caution
⚠️ Do NOT discontinue any prescribed thyroid medication, anti‑epileptic, or hormone therapy without explicit instruction from your treating physician. Abrupt withdrawal may trigger severe metabolic or neurological deterioration.
Safety Exclusion Criteria & Emergency Red Flags
- Mandatory pre‑requisite: A genetic counselling session with a completed three‑generation pedigree chart is required before sample collection.
- Sample rejection: Hemolysed, clotted, or insufficient whole blood/DNA will necessitate recollection at no additional patient cost.
- Contraindications for home collection: Individuals with known severe coagulopathy or those currently receiving high‑dose anticoagulants must be assessed for venipuncture safety.
- Emergency red flags: If the patient develops seizures, sudden loss of consciousness, severe respiratory distress, or refractory myxedema‑like symptoms, seek immediate emergency care—do not wait for genetic results.
- Consent for minors: Per Federal Decree‑Law No. 4 of 2016 on Medical Liability, a legal guardian’s written informed consent is mandatory; test results are released exclusively to the guardian and the referring physician.
Patient FAQ & Clinical Guidance
1. What does the SLC16A2 NGS test detect, and how accurate is it for Allan‑Herndon‑Dudley syndrome?
This test sequences the entire SLC16A2 gene with >99.9% analytical sensitivity, detecting point mutations, insertions/deletions, and copy number variations that cause MCT8 deficiency. Confirmatory diagnosis enables appropriate management and family planning.
2. What is the turnaround time, and will my insurance cover the 2,800 AED cost?
Results are delivered within 3–4 Weeks from arrival of a properly collected sample. Our insurance team verifies eligibility upfront via WhatsApp at +971 54 548 8731 before collection.
3. Is a doctor’s referral required, and can I get testing done at home?
A referral from a neurologist, clinical geneticist, or pediatric neurologist is strongly recommended to ensure clinical appropriateness. Our licensed phlebotomists perform VIP mobile home collection from 8 AM to 11 PM daily, with temperature-controlled cold-chain logistics.
UAE Regulatory & Data Privacy Adherence
- Data Protection: Fully compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Confidentiality: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: All clinical procedures follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Accreditation: ISO 9001:2015 Certified (Cert. INT/EGQ/2509DA/3139).
- Facility: DNA Labs UAE – DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | SLC16A2 Gene Full Sequencing (MCT8) – Allan-Herndon-Dudley Syndrome NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (5 mL in EDTA tube) |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene exons + splice sites |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 29564-7 |
| DHA Facility License & Laboratory Address | DNA Labs UAE – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE License No. 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians